# A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor

> **NCT00209326** · PHASE2 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 163 (actual)

## Conditions studied

- Labor, Premature
- Premature Birth

## Interventions

- **DRUG:** FE200440

## Key facts

- **NCT ID:** NCT00209326
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2006-07
- **Final completion:** 2006-08
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2011-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209326, "A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00209326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*